MicroRNA‑29a is involved lipid metabolism dysfunction and insulin resistance in C2C12 myotubes by targeting PPARδ

MLA

Yun Liu, et al. “MicroRNA‑29a Is Involved Lipid Metabolism Dysfunction and Insulin Resistance in C2C12 Myotubes by Targeting PPARδ.” Molecular Medicine Reports, Apr. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....26a75c4c5c7dca11f7b6ac03fadb5abc&authtype=sso&custid=ns315887.

APA

Yun Liu, Chen Chen, Qianyi Wang, Yu Zeng, Cuilian Jiang, Peng Wu, & Yajun Chen. (2018). MicroRNA‑29a is involved lipid metabolism dysfunction and insulin resistance in C2C12 myotubes by targeting PPARδ. Molecular Medicine Reports.

Chicago

Yun Liu, Chen Chen, Qianyi Wang, Yu Zeng, Cuilian Jiang, Peng Wu, and Yajun Chen. 2018. “MicroRNA‑29a Is Involved Lipid Metabolism Dysfunction and Insulin Resistance in C2C12 Myotubes by Targeting PPARδ.” Molecular Medicine Reports, April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....26a75c4c5c7dca11f7b6ac03fadb5abc&authtype=sso&custid=ns315887.